Sassi Nir 4
4 · Indaptus Therapeutics, Inc. · Filed Aug 6, 2021
Insider Transaction Report
Form 4
Sassi Nir
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-08-04+35,000→ 35,000 totalExercise: $8.87Exp: 2026-08-04→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable over a period of twelve months in four equal quarterly installments and accelerate upon termination of Mr. Sassi's consulting agreement with Indaptus Therapeutics, Inc.